Characterization of clinical infection and drug resistance of group B streptococcus in Chengdu, China.
Wang Q, Huang Y, Liu X, Deng L, Xia J, Wen F, Liu C, Zhu X, Zhang J.
Indian J Med Microbiol. 2024 Nov-Dec;52:100742. doi: 10.1016/j.ijmmb.2024.100742. Epub 2024 Oct 9.
PMID:39374785
Group B Streptococcus transcriptome when interacting with brain endothelial cells.
Vollmuth N, Bridgers BE, Armstrong ML, Wood JF, Gildea AR, Espinal ER, Hooven TA, Barbieri G, Westermann AJ, Sauerwein T, Foerstner KU, Schubert-Unkmeir A, Kim BJ.
J Bacteriol. 2024 Jun 20;206(6):e0008724. doi: 10.1128/jb.00087-24. Epub 2024 May 21.
PMID:38771039
The SaeRS two-component system regulates virulence gene expression in group B Streptococcus during invasive infection.
Coppolino F, De Gaetano GV, Claverie C, Sismeiro O, Varet H, Legendre R, Pellegrini A, Berbiglia A, Tavella L, Lentini G, Famà A, Barbieri G, Pietrocola G, Teti G, Firon A, Beninati C.
mBio. 2024 Sep 11;15(9):e0197524. doi: 10.1128/mbio.01975-24. Epub 2024 Aug 19.
PMID:39158291
Invasive Streptococcus agalactiae (group B streptococcus) infection with toxic shock-like syndrome: A report of a fatal non-pregnant case and a review of the literature.